Status:
ENROLLING_BY_INVITATION
Long Term Follow-up Study for Subjects Administered CLBR001
Lead Sponsor:
Calibr, a division of Scripps Research
Conditions:
Long Term Follow-Up
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this Long Term Follow-Up observational study is to monitor subjects who have received CLBR001, a lentiviral vector based chimeric antigen receptor, for delayed adverse events that may be a...
Detailed Description
In line with FDA guidance on Long Term Follow-Up (LTFU) after administration of human gene therapy products, any subject who receives CLBR001 on any Calibr treatment study will participate in LTFU on ...
Eligibility Criteria
Inclusion
- Subjects who received at least one CLBR001 cell dose.
Exclusion
- None
Key Trial Info
Start Date :
August 28 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2044
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06882317
Start Date
August 28 2025
End Date
February 1 2044
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virtual Research Group- Premier Research
Morrisville, North Carolina, United States, 27560